Advertisement
Racial/ethnic variation is evident in lung cancer incidence and mortality among postmenopausal women

Modifiable Factors Affect Racial Differences in Lung Cancer

0
No racial/ethnic differences in the risk of lung cancer death among women in fully adjusted models
Prices at hospitals in monopoly markets are 15 percent higher than those at hospitals in areas with at least four providers

Higher Hospital Prices in U.S. ‘Monopoly Markets’

0
Hospital prices positively associated with indicators of hospital market power
In a practice bulletin published in the January issue of Obstetrics & Gynecology

ACOG: New Recommendations for Cervical Cancer Screening

0
Recommendations provide guidance on frequency of screening, appropriate screening methods
Comprehensive cigarette bans are most effective at limiting smoking among casual users

Both Smoking Bans and Cigarette Taxes Deter Smokers

0
Bans seem better for social smokers; heavy smokers primarily deterred by taxes

Meta-Analysis Confirms miR-21 Expression, Laryngeal CA Link

0
High miR-21 expression seen in laryngeal cancer versus non-neoplasm tissue
In order to prevent denials

Specific, Consistent ICD-10 Coding Key to Timely Payments

0
Tips to prevent denials include checking EHR selection against documentation, being specific
The American Cancer Society's Chief Executive Officers Challenge can increase implementation of health promotion practices

CEO Challenge Spurs Workers to Adopt Healthy Practices

0
Increase in cancer screening, healthy eating, physical activity, tobacco cessation at one-year follow-up
Men who have sex with men who have abstained from sex for one year will now be allowed to donate blood in the United States. The new policy

FDA Lifts Ban on Blood Donations by Men Who Have Sex With Men

0
National blood surveillance system will help agency ensure safety of the blood supply
For premenopausal women with breast cancer

Adding Triptorelin to Breast CA Chemo May Up Ovarian Recovery

0
Findings for premenopausal women with hormone-positive or hormone-negative breast cancer
Pembrolizumab (Keytruda) may extend survival for patients with advanced non-small-cell lung cancer

Pembrolizumab Shows Promise in Metastatic NSCLC

0
In study, the immune-based therapy beat docetaxel with fewer side effects